首页> 外文OA文献 >Elucidation of the physicochemical properties and potency of siRNA-loaded small-sized lipid nanoparticles for siRNA delivery
【2h】

Elucidation of the physicochemical properties and potency of siRNA-loaded small-sized lipid nanoparticles for siRNA delivery

机译:阐明了装载siRNA的小脂质纳米颗粒的物理化学性质和对siRNA传递的效力

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Because nanoparticles with diameters less than 50 nm penetrate stromal-rich tumor tissues more efficiently, the synthesis of small-sized nanoparticles encapsulating short interfering RNA (siRNA) is important in terms of realizing novel siRNA medicine for the treatment of various cancers. Lipid nanoparticles (LNPs) are the leading systems for the delivery of siRNA in vivo. Limit size LNPs were successfully synthesized using a microfluidic mixing technique. However, the physicochemical properties and potential for in vivo siRNA delivery of the limit-size LNPs have not been examined in detail. In the present study, we prepared LNPs with different diameters from 32 to 67 nm using a microfluidic mixing devise and examined the physicochemical properties of the particles and the potential for their use in delivering siRNA in vitro and in vivo to liver. Reducing the size of the LNPs causes poor-packing and an increased surface area, which result in their instability in serum. Moreover, it was revealed that the ability of endosomal escape (cytosolic siRNA release) of the smaller LNPs is subject to inhibition by serum compared to that of larger counterparts. Taken together, an increase in packing and avoiding the adsorption of serum components are key strategies for the development of next-generation highly potent and small-sized LNPs. (C) 2016 Elsevier B.V. All rights reserved.
机译:因为直径小于50 nm的纳米颗粒可以更有效地穿透富含基质的肿瘤组织,所以封装短干扰RNA(siRNA)的小尺寸纳米颗粒的合成对于实现用于治疗各种癌症的新型siRNA药物非常重要。脂质纳米颗粒(LNP)是体内siRNA递送的主要系统。使用微流体混合技术成功合成了极限大小的LNP。但是,尚未详细检查极限大小的LNP的理化性质和体内siRNA传递的潜力。在本研究中,我们使用微流体混合装置制备了直径范围为32至67 nm的LNP,并检查了颗粒的理化性质以及将其用于体外和体内向肝脏递送siRNA的潜力。减小LNP的大小会导致包装不良和表面积增加,从而导致其在血清中的不稳定。此外,还发现,与较大的LNP相比,较小的LNP的内体逃逸能力(胞质siRNA释放)受血清的抑制。总而言之,增加装填量和避免吸附血清成分是开发下一代高效低分子量LNP的关键策略。 (C)2016 Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号